Industry News

From Bloomberg From Businessweek From Around the Web Show All
Innovent doses first patient with IBI188 under Phase I clinical trial in China
M2 Communications - 01/15/2019 5:51 AM ET
Amneal wins US FDA approval for Rivastigmine Transdermal System
M2 Communications - 01/15/2019 5:37 AM ET
Charlotte's Web Hemp Harvest Increases 10X, Building Inventory to Meet Growing CBD Product Demand
Canada Newswire - 01/15/2019 5:30 AM ET
Charlotte's Web Hemp Harvest Increases 10X, Building Inventory to Meet Growing CBD Product Demand
PR Newswire - 01/15/2019 5:30 AM ET
Amid Onpattro launch, Alnylam raises $387.5M
M2 Communications - 01/15/2019 5:24 AM ET
MSKCC says senior execs may not hold industry board seats
M2 Communications - 01/15/2019 5:22 AM ET
Abbott wins US FDA approval for the Amplatzer Piccolo Occluder to treat patent ductus arteriosus (PDA) in premature babies
M2 Communications - 01/15/2019 5:07 AM ET
HarborOne Bancorp's board elects Mandy Lee Berman and Damian W. Wilmot as directors
M2 Communications - 01/15/2019 5:00 AM ET
FDA approves Cabometyx for liver cancer
M2 Communications - 01/15/2019 4:50 AM ET
MSKCC says senior execs may not hold industry board seats
M2 Communications - 01/15/2019 4:49 AM ET
Acamdemics questioned on Planetary Health
M2 Communications - 01/15/2019 4:40 AM ET
Ascletis to develop Alphamab's PD-L1 antibody for HBV in China
M2 Communications - 01/15/2019 4:35 AM ET
BeiGene's Btk inhibitor gets U.S. breakthrough designation
M2 Communications - 01/15/2019 4:35 AM ET
Keith Stein Replaces Trevor Dixon and Josef Hocher on Invictus' Board
Canada Newswire - 01/15/2019 4:30 AM ET
Keith Stein Replaces Trevor Dixon and Josef Hocher on Invictus' Board
PR Newswire - 01/15/2019 4:30 AM ET
Aslan dips after Phase II gastric cancer miss
M2 Communications - 01/15/2019 4:02 AM ET
Sanofi wins US FDA approval for expanded repeat vaccination of Adacel against tetanus, diphtheria and pertussis
M2 Communications - 01/15/2019 4:00 AM ET
Children's Hospital hires new inclusion executive [Star Tribune (Minneapolis)]
McClatchy-Tribune - 01/15/2019 3:51 AM ET
Hansa Medical AB Provides Regulatory Update for Imlifidase in Kidney Transplantation
PR Newswire - 01/15/2019 2:13 AM ET
European Medicines Agency validates Oasmia Pharmaceutical AB’s application to add efficacy data to the approved Apealea® product information
GlobeNewswire - 01/15/2019 2:00 AM ET
Achim von Leoprechting promoted to become CEO of Tecan after retirement of David Martyr
Thomson Reuters ONE - 01/15/2019 1:20 AM ET
First Ohio medical marijuana dispensary opens 9 a.m. Wednesday [Advance Ohio Media, Cleveland]
McClatchy-Tribune - 01/15/2019 12:01 AM ET
TASE workers blocking public offering [Globes, Tel Aviv, Israel]
McClatchy-Tribune - 01/15/2019 12:01 AM ET
IAG weighs SBI General Insurance stake sale [Mint, New Delhi]
McClatchy-Tribune - 01/15/2019 12:01 AM ET
Marlborough FinCom OK's TIF deal with Candela Corp. [MetroWest Daily News, Framingham, Mass.]
McClatchy-Tribune - 01/15/2019 12:01 AM ET
 
Previous
1 - 10
 
11 - 20
 
21
22
23
24
25
26
27
28
29
30
31 - 40
41 - 50
51 - 60
61 - 70
71 - 80
81 - 90
91 - 100
101 - 110
111 - 116
 
Next

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Financials459 Articles
Consumer Discretionary457 Articles
Information Technology451 Articles
Health Care430 Articles
Industrials357 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

Close